Skip to Content
Merck
CN

G9137

Gly-Pro 4-methoxy-β-naphthylamide

dipeptidylpeptidase IV substrate

Synonym(s):

H-Gly-Pro-4MbNA

Sign In to View Organizational & Contract Pricing.

Select a Size

About This Item

Empirical Formula (Hill Notation):
C18H21N3O3
CAS Number:
42761-76-2
Molecular Weight:
327.38
NACRES:
NA.32
PubChem Substance ID:
24895363
UNSPSC Code:
12352204
MDL number:
MFCD00037726

Key Documents

View All Documentation
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

Product Name

Gly-Pro 4-methoxy-β-naphthylamide, dipeptidylpeptidase IV substrate

InChI

1S/C18H21N3O3/c1-24-16-10-13(9-12-5-2-3-6-14(12)16)20-18(23)15-7-4-8-21(15)17(22)11-19/h2-3,5-6,9-10,15H,4,7-8,11,19H2,1H3,(H,20,23)

SMILES string

COc1cc(NC(=O)C2CCCN2C(=O)CN)cc3ccccc13

InChI key

LSZPYDQEJZWJIJ-UHFFFAOYSA-N

assay

≥98% (TLC)

form

powder

solubility

ethanol: 50 mg/mL, clear, colorless to faintly yellow

storage temp.

−20°C

Quality Level

200

Application

Gly-Pro 4-methoxy-β-naphthylamide has been used as a substrate to evaluate the dipeptidyl peptidase-4 (DPP4) enzymatic activity.

Packaging

Bottomless glass bottle. Contents are inside inserted fused cone.

Substrates

Substrate for Dipeptidyl Aminopeptidase IV

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type P3 (EN 143) respirator cartridges

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number
BCCN8034
BCCK2332
BCCD5973
BCBZ7999
BCBW5291

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Search for a COA

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Gerd Luippold et al.
Diabetes research and clinical practice, 143, 199-203 (2018-07-22)
The two dipeptidyl peptidase (DPP)-4 inhibitors, linagliptin and sitagliptin, were shown to exert different binding kinetics in vitro. Twenty-four hours after oral dosing particularly in vivo inhibition of renal-specific DPP-4 activity was more sustained in Sprague Dawley rats after exposure
Wesley Mah et al.
The American journal of pathology, 187(8), 1717-1735 (2017-06-24)
Compared to skin, wound healing in oral mucosa is faster and produces less scarring, but the mechanisms involved are incompletely understood. Studies in mice have linked high expression of CD26 to a profibrotic fibroblast phenotype, but this has not been
Anna-Lena Mayer et al.
British journal of pharmacology, 178(4), 878-895 (2020-11-11)
Dipeptidyl peptidase 4 (DPP-4) inhibitors are a class of oral glucose-lowering drugs used in the treatment of type 2 diabetes. In a pilot study using human kidney biopsies, we observed high DPP-4 expression in early crescent formation. This glomerular lesion
Wesley Mah et al.
The American journal of pathology, 187(8), 1717-1735 (2017-06-24)
Compared to skin, wound healing in oral mucosa is faster and produces less scarring, but the mechanisms involved are incompletely understood. Studies in mice have linked high expression of CD26 to a profibrotic fibroblast phenotype, but this has not been

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service